ARCHIVES

Central Line Safety Intervention Lowers Patient Infection Rate

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Sen. Brown Introduces Bill on Clinical Trials Coverage

April 3, 2009

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994